These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8611732)
41. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950 [TBL] [Abstract][Full Text] [Related]
42. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466 [TBL] [Abstract][Full Text] [Related]
43. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Vitale M; Zimmer J; Castriconi R; Hanau D; Donato L; Bottino C; Moretta L; de la Salle H; Moretta A Blood; 2002 Mar; 99(5):1723-9. PubMed ID: 11861289 [TBL] [Abstract][Full Text] [Related]
44. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands. Han M; Fallena M; Guo Y; Stastny P Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450 [TBL] [Abstract][Full Text] [Related]
45. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. Koide J; Rivas A; Engleman EG J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816 [TBL] [Abstract][Full Text] [Related]
46. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB; Phillips JH; Figdor CG; Lanier LL J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119 [TBL] [Abstract][Full Text] [Related]
48. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Beelen DW; Ottinger HD; Ferencik S; Elmaagacli AH; Peceny R; Trenschel R; Grosse-Wilde H Blood; 2005 Mar; 105(6):2594-600. PubMed ID: 15536148 [TBL] [Abstract][Full Text] [Related]
49. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625 [TBL] [Abstract][Full Text] [Related]
50. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Reittie JE; Gottlieb D; Heslop HE; Leger O; Drexler HG; Hazlehurst G; Hoffbrand AV; Prentice HG; Brenner MK Blood; 1989 Apr; 73(5):1351-8. PubMed ID: 2495037 [TBL] [Abstract][Full Text] [Related]
51. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068 [TBL] [Abstract][Full Text] [Related]
52. Normal epithelial cells modulating HLA class I surface molecules are susceptible to lysis mediated by CD3(+) and CD3(-) "nonspecific" killer cells. Semino C; Pietra G; Semino A; Falco M; Varaldo M; Melioli G Cell Immunol; 1998 Dec; 190(2):183-90. PubMed ID: 9878119 [TBL] [Abstract][Full Text] [Related]
53. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. Koenecke C; Shaffer J; Alexander SI; Preffer F; Dombkowski D; Saidman SL; Dey B; McAfee S; Spitzer TR; Sykes M Exp Hematol; 2003 Oct; 31(10):911-23. PubMed ID: 14550807 [TBL] [Abstract][Full Text] [Related]
54. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. D'Andrea A; Chang C; Phillips JH; Lanier LL J Exp Med; 1996 Aug; 184(2):789-94. PubMed ID: 8760835 [TBL] [Abstract][Full Text] [Related]
55. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products. Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836 [TBL] [Abstract][Full Text] [Related]
56. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415 [TBL] [Abstract][Full Text] [Related]
57. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
58. In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes. Vinci G; Vernant JP; Nakazawa M; Zohair M; Katz A; Henri A; Rochant H; Breton-Gorius J; Vainchenker W Blood; 1988 Nov; 72(5):1616-21. PubMed ID: 2972326 [TBL] [Abstract][Full Text] [Related]
59. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671 [TBL] [Abstract][Full Text] [Related]